Oxford Asset Management »

Acelyrin shares owned by Oxford Asset Management

Quarter-by-quarter ownership of Acelyrin (SLRN) shares owned by Oxford Asset Management from 13F filings

Historical chart of Oxford Asset Management investment in Acelyrin

Tip: Access up to 7 years of quarterly data

All positions including Acelyrin held by Oxford Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelyrin by Oxford Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $54k 12k 4.41

More positions owned by Oxford Asset Management

Spdr Ser Tr S&p Biotech (XBI)
Cintas Corporation (CTAS)
Verizon Communications (VZ)
Veeva Sys Cl A Com (VEEV)
Peregrine Pharmaceuticals (CDMO)
Tractor Supply Company (TSCO)
Maplebear (CART)
Comcast Corp Cl A (CMCSA)
Progressive Corporation (PGR)
Johnson & Johnson (JNJ)
Us Bancorp Del Com New (USB)
Metropcs Communications (TMUS)
Newmont Mining Corporation (NEM)
General Motors Company (GM)
EOG Resources (EOG)

View all positions for Oxford Asset Management

Top funds holding Acelyrin

T. Rowe Price Investment Management
AyurMaya Capital Management Company
BlackRock
Millennium Management
Citadel Advisors
Vanguard Group
OrbiMed Advisors
venBio Partners
Tybourne Capital Management
Blue Owl Capital Holdings
General Atlantic
Samsara BioCapital
Morgan Stanley
Opaleye Management
Palo Alto Investors

View all funds holding Acelyrin